Latest Product Development News

Orthocell Limited has posted a record quarterly revenue of A$2.73 million, driven by strong Australian sales of its nerve repair product Remplir™, with US market expansion poised to accelerate in FY26.

Harvest Technology Group has raised $500,000 through unsecured convertible notes with a 15% annual interest rate, supporting its strategic three-year profit plan. The notes include attached options exercisable over two years, pending shareholder approval.

Microba Life Sciences has announced a $14.5 million capital raising, including a $2 million fully underwritten Securities Purchase Plan (SPP) and a $12.5 million Placement, aimed at fast-tracking commercialisation of its microbiome diagnostic tests in Australia and the UK.

Atomo Diagnostics has successfully closed a Share Purchase Plan and secured shareholder approval for a Tranche 2 Placement, raising a combined $1.53 million to support its ongoing operations.

Sprintex secures a key deposit from Mest Water to develop new compressors for mobile manure processing systems, leveraging a Dutch government subsidy aimed at thousands of small farms.

Adherium Limited has announced a partially underwritten entitlement offer aiming to raise approximately A$4.5 million through the issuance of new shares and options at a significant discount. The capital raise is designed to accelerate patient onboarding and product development for its respiratory monitoring technology.

Firebrick Pharma has raised $0.2 million in a placement well below its $1.6 million target, prompting a review of its expansion and product development plans for Nasodine.

DroneShield Limited has reported a record-breaking first quarter in 2025, doubling its revenue year-over-year and nearly tripling its SaaS income, underpinned by a robust $2.41 billion sales pipeline and strong global defense spending.

Xero Limited has agreed to acquire Melio Limited, a leading US SMB bill pay platform, for US$2.5 billion, marking a significant leap in its US growth strategy. The deal is backed by a substantial A$1.85 billion equity raise and aims to accelerate revenue and market presence by FY28.

Adherium Limited has announced an accelerated non-renounceable entitlement offer to raise approximately A$4 million, issuing new shares and options to fund expansion and product development. The offer includes a Top-Up Facility and is partially underwritten, signaling a strategic push to scale its respiratory monitoring technology.

Fortifai Limited has successfully raised $2.3 million through an upsized share placement, aiming to bolster its AI Gaming Lab and technology partnerships. The capital injection will support ongoing operations and strategic growth initiatives.

Microba Life Sciences has raised $14.5 million to accelerate clinical adoption of its microbiome testing products, while narrowing its FY25 revenue guidance and signing a strategic UK laboratory agreement.